These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 541522)

  • 21. Interferon in nasal secretions from infants with viral respiratory tract infections.
    McIntosh K
    J Pediatr; 1978 Jul; 93(1):33-6. PubMed ID: 650342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Formation of secretory antibodies in experimental influenza infection].
    Agranovskaia EN; Mal'tseva AI; Zlydnikov DM; Krylov VA; Shvartsman IaS
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):74-7. PubMed ID: 1221704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of "Alice" influenza virus vaccine in normal healthy adults.
    Zaky DA; Douglas RG; Betts RF; Roth FK; Rinehart CJ; Hogan PW
    J Infect Dis; 1976 Jun; 133(6):669-75. PubMed ID: 946973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretory immune response after nasal vaccination with live attenuated influenza viruses.
    Crifö S; Vella S; Filiaci F; Resta S; Rocchi G
    Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of influenza specific antibody secreting cells in nasal mucosa.
    Brokstad KA; Cox RJ; Eriksson JC; Olofsson J; Jonsson R; Davidsson A
    Scand J Immunol; 2001; 54(1-2):243-7. PubMed ID: 11439173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Monoclonal immunoenzyme test-system for evaluating secretory immunity to influenza A and B viruses].
    Naĭkhin AN; Donina SA; Kustikova IuG; Katorgina LG; Rudenko LG
    Vopr Virusol; 1997; 42(5):212-6. PubMed ID: 9424845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory anti-influenza immunity.
    Shvartsman YS; Zykov MP
    Adv Immunol; 1976; 22():291-330. PubMed ID: 769501
    [No Abstract]   [Full Text] [Related]  

  • 28. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus.
    Suzuki T; Kawaguchi A; Ainai A; Tamura S; Ito R; Multihartina P; Setiawaty V; Pangesti KN; Odagiri T; Tashiro M; Hasegawa H
    Proc Natl Acad Sci U S A; 2015 Jun; 112(25):7809-14. PubMed ID: 26056267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of antibody to matrix protein in experimental human influenza A virus infections.
    Cretescu L; Beare AS; Schild GC
    Infect Immun; 1978 Nov; 22(2):322-7. PubMed ID: 730356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunoprecipitin study of the incidence of influenza A antibodies in animal sera in the Ottawa area.
    Fyson RE; Westwood JC; Brunner AH
    Can J Microbiol; 1975 Jul; 21(7):1089-101. PubMed ID: 167931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immune responses during asthma and influenza co-morbidity in mice.
    Doorley LA; LeMessurier KS; Iverson AR; Palipane M; Samarasinghe AE
    Immunobiology; 2017 Dec; 222(12):1064-1073. PubMed ID: 28889999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
    Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of the functional activity of antibodies in influenza immunity].
    Naĭkhin AN; Artem'eva SA; Bosak LV; Katorgina LG
    Vestn Ross Akad Med Nauk; 1995; (9):32-6. PubMed ID: 7580411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.
    Asahi-Ozaki Y; Yoshikawa T; Iwakura Y; Suzuki Y; Tamura S; Kurata T; Sata T
    J Med Virol; 2004 Oct; 74(2):328-35. PubMed ID: 15332283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity after infections with Myxoviruses.
    Majer M
    Infection; 1976; 4(2):80-3. PubMed ID: 59707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunological reactions in the secretions of volunteers vaccinated against influenza by aerosol and intranasally].
    Pershin BB; Romanov VL; Kvirikadze VV; Stefani DV; Torichneva LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):35-9. PubMed ID: 373335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.
    Jackson LA; Cherry JD; Wang SP; Grayston JT
    Clin Infect Dis; 2000 Jul; 31(1):3-6. PubMed ID: 10913388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine.
    Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C
    Virologie; 1985; 36(3):187-94. PubMed ID: 4071977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.